StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30119% above fair value
$4.07+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

MannKind net income

Net income is the profit left for shareholders after every expense, interest and tax.

MannKind's net income for the twelve months ending Jun 30, 2026 was -$43.61M, down 233.0% year over year. For fiscal 2025 it was $5.86M, down 78.7% from the year before. The highest annual figure on record is $125.66M in fiscal 2016.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.86M-78.7%
FY2024Dec 31, 2024$27.59M–
FY2023Dec 31, 2023-$11.94M–
FY2022Dec 31, 2022-$87.40M–
FY2021Dec 31, 2021-$80.93M–
FY2020Dec 31, 2020-$57.24M–
FY2019Dec 31, 2019-$51.90M–
FY2018Dec 31, 2018-$86.98M–
FY2017Dec 31, 2017-$117.33M-193.4%
FY2016Dec 31, 2016$125.66M–
FY2015Dec 31, 2015-$368.45M–
FY2014Dec 31, 2014-$198.38M–
FY2013Dec 31, 2013-$191.49M–
FY2012Dec 31, 2012-$169.37M–
FY2011Dec 31, 2011-$160.80M–
FY2010Dec 31, 2010-$170.56M–
FY2009Dec 31, 2009-$220.10M–
FY2008Dec 31, 2008-$303.04M–
FY2007Dec 31, 2007-$293.19M–
FY2006Dec 31, 2006-$230.55M–
FY2005Dec 31, 2005-$114.34M–
FY2004Dec 31, 2004-$75.99M–
FY2003Dec 31, 2003-$65.88M–
FY2002Dec 31, 2002-$206.27M–
FY2001Dec 31, 2001-$48.25M–
FY2000Dec 31, 2000-$24.66M–
FY1999Dec 31, 1999-$5.68M–
FY1998Dec 31, 1998-$3.33M–
FY1997Dec 31, 1997-$2.28M–
FY1996Dec 31, 1996-$2.57M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.03M-2949.1%
Q1 FY2026Mar 31, 2026-$16.62M-226.3%
Q4 FY2025Dec 31, 2025-$15.95M-314.9%
Q3 FY2025Sep 30, 2025$7.99M-30.9%
Q2 FY2025Jun 30, 2025$668.00K–
Q1 FY2025Mar 31, 2025$13.16M+23.8%
Q4 FY2024Dec 31, 2024$7.42M+429.8%
Q3 FY2024Sep 30, 2024$11.55M+571.1%
Q2 FY2024Jun 30, 2024-$2.01M–
Q1 FY2024Mar 31, 2024$10.63M–
Q4 FY2023Dec 31, 2023$1.40M–
Q3 FY2023Sep 30, 2023$1.72M–
Q2 FY2023Jun 30, 2023-$5.27M–
Q1 FY2023Mar 31, 2023-$9.80M–
Q4 FY2022Dec 31, 2022-$17.95M–
Q3 FY2022Sep 30, 2022-$14.43M–
Q2 FY2022Jun 30, 2022-$29.02M–
Q1 FY2022Mar 31, 2022-$26.00M–
Q4 FY2021Dec 31, 2021-$28.06M–
Q3 FY2021Sep 30, 2021-$4.43M–
Q2 FY2021Jun 30, 2021-$35.52M–
Q1 FY2021Mar 31, 2021-$12.92M–
Q4 FY2020Dec 31, 2020-$26.41M–
Q3 FY2020Sep 30, 2020-$11.26M–
Q2 FY2020Jun 30, 2020-$10.25M–
Q1 FY2020Mar 31, 2020-$9.32M–
Q4 FY2019Dec 31, 2019-$14.26M–
Q3 FY2019Sep 30, 2019-$10.37M–
Q2 FY2019Jun 30, 2019-$12.39M–
Q1 FY2019Mar 31, 2019-$14.88M–
Q4 FY2018Dec 31, 2018-$9.75M–
Q3 FY2018Sep 30, 2018-$24.17M–
Q2 FY2018Jun 30, 2018-$22.68M–
Q1 FY2018Mar 31, 2018-$30.39M–
Q4 FY2017Dec 31, 2017-$32.78M-160.7%
Q3 FY2017Sep 30, 2017-$32.89M-126.0%
Q2 FY2017Jun 30, 2017-$35.34M–
Q1 FY2017Mar 31, 2017-$16.32M–
Q4 FY2016Dec 31, 2016$53.98M–
Q3 FY2016Sep 30, 2016$126.52M–

More MannKind figures

See a number that looks wrong?